APACHE II score does not predict multiple organ failure or mortality in postoperative surgical patients

Area of Science:

• Critical Care Medicine
• Surgical Outcomes Research
• Prognostic Factor Analysis

Background:

• The APACHE II (Acute Physiology and Chronic Health Care) score is a widely used severity-of-illness classification system.
• Accurate prediction of multiple organ failure syndrome (MOFS) and mortality is crucial for patient management and quality assessment in intensive care units (ICUs).

Purpose of the Study:

• To evaluate the predictive capability of the APACHE II score for MOFS and mortality in a general surgery ICU population.
• To identify alternative clinical or laboratory markers that may better predict MOFS and mortality.

Main Methods:

• A prospective clinical study was conducted over one year in a university general surgery ICU.
• Admission APACHE II scores were collected for 92 qualifying patients.
• Patient outcomes, including MOFS development, survival, and mortality, were recorded and analyzed.

Main Results:

• The APACHE II score demonstrated poor clinical utility in predicting MOFS and mortality.
• The system significantly underestimated the risk of MOFS development.
• Time-dependent changes in PaO2/FiO2 ratio, serum lactate, creatinine, and bilirubin levels were significant predictors of MOFS and mortality.

Conclusions:

• The APACHE II score is not a reliable predictor of MOFS or mortality in this surgical ICU cohort.
• Dynamic physiological and biochemical markers offer superior prognostic value.
• Development of improved biomarkers for cell injury is needed for better clinical decision-making and quality assurance in surgical critical care.